Stroke Research Today is a free monthly online journal that collates and summarizes the latest research about Stroke, including details on treatment, recovery, rehabilitation, signs, symptoms.

Volume 6 (2009), Issue 4 (April)

1. Inherited prothrombotic risk factors in children with stroke, transient ischemic attack, or migraine.
   Pediatrics, 123(4): e653-60. [Abstract] [Full-text]
2. Outcomes of intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 90 years or older.
   Mayo Clin Proc, 84(4): 334-8. [Abstract] [Full-text]
3. IL-20 is regulated by hypoxia-inducible factor and up-regulated after experimental ischemic stroke.
   J Immunol, 182(8): 5003-12. [Abstract] [Full-text]
4. Resolution of tracheal aspiration after the acute phase of stroke-related oropharyngeal Dysphagia.
   Am J Gastroenterol, 104(4): 923-32. [Abstract] [Full-text]
5. Silent embolic infarcts on computed tomography brain scans and risk of ipsilateral hemispheric events in patients with asymptomatic internal carotid artery stenosis.
   J Vasc Surg, 49(4): 902-9. [Abstract] [Full-text]
6. A method for standardizing procedures in rehabilitation: use in the extremity constraint induced therapy evaluation multisite randomized controlled trial.
   Arch Phys Med Rehabil, 90(4): 663-8. [Abstract] [Full-text]
7. Pediatric stroke recovery: a descriptive analysis.
   Arch Phys Med Rehabil, 90(4): 657-62. [Abstract] [Full-text]
8. Silent ischemic infarcts are associated with hemorrhage burden in cerebral amyloid angiopathy.
   Neurology, 72(14): 1230-5. [Abstract] [Full-text]
9. MDCT features of cardiothoracic sources of stroke.
   Clin Radiol, 64(5): 550-9. [Abstract] [Full-text]
10. Delayed treatment with carboxy-PTIO permits a 4-h therapeutic window of opportunity and prevents against ischemia-induced energy depletion following permanent focal cerebral ischemia in mice.
    Neurochem Res, 34(6): 1157-66. [Abstract] [Full-text]
11. Social isolation alters neuroinflammatory response to stroke.
    Proc Natl Acad Sci U S A, 106(14): 5895-900. [Abstract] [Full-text]
12. Deficiency of von Willebrand factor protects mice from ischemic stroke.
    Blood, 113(15): 3600-3. [Abstract] [Full-text]
13. Evidence of a logarithmic relationship between motor capacity and actual performance in daily life of the paretic arm following stroke.
    J Rehabil Med, 41(5): 327-31. [Abstract] [Full-text]
14. Long-term effect of comorbidity on the course of physical functioning in patients after stroke and with multiple sclerosis.
    J Rehabil Med, 41(5): 322-6. [Abstract] [Full-text]
15. Muscle function of knee extensors and flexors after stroke is selectively impaired at shorter muscle lengths.
    J Rehabil Med, 41(5): 317-21. [Abstract] [Full-text]
16. Transcutaneous electrical stimulation on acupuncture points improves muscle function in subjects after acute stroke: a randomized controlled trial.
    J Rehabil Med, 41(5): 312-6. [Abstract] [Full-text]
17. Combination antiplatelet therapy for secondary stroke prevention: enhanced efficacy or double trouble?
    Am J Cardiol, 103(8): 1107-12. [Abstract] [Full-text]
18. Utilization of TCD screening for primary stroke prevention in children with sickle cell disease.
    Neurology, 72(15): 1316-21. [Abstract] [Full-text]
19. Cerebral arteriolar thromboembolism in idiopathic hypereosinophilic syndrome.
    Arch Neurol, 66(4): 528-31. [Abstract] [Full-text]
20. Treatment effects for which shift or binary analyses are advantageous in acute stroke trials.
    Neurology, 72(15): 1310-5. [Abstract] [Full-text]
21. Four blood pressure indexes and the risk of stroke and myocardial infarction in Japanese men and women: a meta-analysis of 16 cohort studies.
    Circulation, 119(14): 1892-8. [Abstract] [Full-text]
22. Pediatric stroke: do clinical factors predict delays in presentation?
    J Pediatr, 154(5): 727-32. [Abstract] [Full-text]
23. Stroke rates: 1980-2000: the Minnesota Stroke Survey.
    Am J Epidemiol, 169(9): 1070-8. [Abstract] [Full-text]
24. Central poststroke pain: a review of pathophysiology and treatment.
    Anesth Analg, 108(5): 1645-57. [Abstract] [Full-text]
25. Phenylephrine ameliorates cerebral cytotoxic edema and reduces cerebral infarction volume in a rat model of complete unilateral carotid artery occlusion with severe hypotension.
    Anesth Analg, 108(5): 1631-7. [Abstract] [Full-text]
26. Location of lacunar infarcts correlates with cognition in a sample of non-disabled subjects with age-related white-matter changes: the LADIS study.
    J Neurol Neurosurg Psychiatry, 80(5): 478-83. [Abstract] [Full-text]
27. Rationale and design of RE-LY: randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran.
    Am Heart J, 157(5): 805-10, 810.e1-2. [Abstract] [Full-text]
28. The patient with atrial fibrillation.
    Am J Med, 122(5): 415-8. [Abstract] [Full-text]
29. Akinetic mutism--not coma.
    Age Ageing, 38(3): 350-1. [Abstract] [Full-text]
30. Movement disorders after stroke.
    Age Ageing, 38(3): 260-6. [Abstract] [Full-text]
31. Sex differences in the response to activation of the poly (ADP-ribose) polymerase pathway after experimental stroke.
    Exp Neurol, 217(1): 210-8. [Abstract] [Full-text]
32. CD47 gene knockout protects against transient focal cerebral ischemia in mice.
    Exp Neurol, 217(1): 165-70. [Abstract] [Full-text]
33. Genomewide association studies of stroke.
    N Engl J Med, 360(17): 1718-28. [Abstract] [Full-text]
34. Temporal trends in the risks of stroke and death due to endarterectomy for symptomatic carotid stenosis: an updated systematic review.
    Eur J Vasc Endovasc Surg, 37(5): 504-11. [Abstract] [Full-text]
35. Early carotid endarterectomy after intravenous thrombolysis for acute ischaemic stroke.
    Eur J Vasc Endovasc Surg, 37(5): 512-8. [Abstract] [Full-text]
36. Metabolic syndrome: A predictor of adverse outcomes after carotid revascularization.
    J Vasc Surg, 49(5): 1172-80.e1; discussion 1180. [Abstract] [Full-text]
37. Quality of care and length of hospital stay among patients with stroke.
    Med Care, 47(5): 575-82. [Abstract] [Full-text]
38. A multimodal approach to the prevention of postoperative stroke in patients undergoing coronary artery bypass surgery.
    Am J Surg, 197(5): 587-90. [Abstract] [Full-text]
39. Hormone replacement therapy and cardiovascular health in the United States.
    Med Care, 47(5): 600-6. [Abstract] [Full-text]
40. CD36: a multi-modal target for acute stroke therapy.
    J Neurochem, 109: 126-32. [Abstract] [Full-text]
41. Advances in interventional neuroradiology.
    Stroke, 40(5): e305-12. [Abstract] [Full-text]
42. Identifying patients at high risk for poor outcome after intra-arterial therapy for acute ischemic stroke.
    Stroke, 40(5): 1780-5. [Abstract] [Full-text]
43. Invasive cortical stimulation to promote recovery of function after stroke: a critical appraisal.
    Stroke, 40(5): 1926-31. [Abstract] [Full-text]
44. Trends for blood pressure and its contribution to stroke incidence in the middle-aged Japanese population: the Circulatory Risk in Communities Study (CIRCS).
    Stroke, 40(5): 1571-7. [Abstract] [Full-text]
45. Incidence of stroke in europe at the beginning of the 21st century.
    Stroke, 40(5): 1557-63. [Abstract] [Full-text]
46. Quantitative t2 values predict time from symptom onset in acute stroke patients.
    Stroke, 40(5): 1612-6. [Abstract] [Full-text]
47. Hyperfibrinogenemia and functional outcome from acute ischemic stroke.
    Stroke, 40(5): 1687-91. [Abstract] [Full-text]
48. Regional implementation of the stroke systems of care model: recommendations of the northeast cerebrovascular consortium.
    Stroke, 40(5): 1793-802. [Abstract] [Full-text]
49. Reduction in incident stroke risk with vigorous physical activity: evidence from 7.7-year follow-up of the national runners' health study.
    Stroke, 40(5): 1921-3. [Abstract] [Full-text]
50. Differential infraslow (<0.1 Hz) cortical activations in the affected and unaffected hemispheres from patients with subacute stroke demonstrated by noninvasive DC-magnetoencephalography.
    Stroke, 40(5): 1683-6. [Abstract] [Full-text]
51. Results of the MRI substudy of the intravenous magnesium efficacy in stroke trial.
    Stroke, 40(5): 1704-9. [Abstract] [Full-text]
52. Relationships between cerebral perfusion and reversibility of acute diffusion lesions in DEFUSE: insights from RADAR.
    Stroke, 40(5): 1692-7. [Abstract] [Full-text]
53. Relation between cerebral perfusion territories and location of cerebral infarcts.
    Stroke, 40(5): 1617-22. [Abstract] [Full-text]
54. Periventricular white matter lucencies relate to low vitamin B12 levels in patients with small vessel stroke.
    Stroke, 40(5): 1623-6. [Abstract] [Full-text]
55. Blood markers for the prognosis of ischemic stroke: a systematic review.
    Stroke, 40(5): e380-9. [Abstract] [Full-text]
56. Framingham stroke risk function in a large population-based cohort of elderly people: the 3C study.
    Stroke, 40(5): 1564-70. [Abstract] [Full-text]
57. A method to determine stroke trial success using multidimensional pooled control functions.
    Stroke, 40(5): 1803-10. [Abstract] [Full-text]
58. Swallowing disturbance pattern relates to brain lesion location in acute stroke patients.
    Stroke, 40(5): 1903-6. [Abstract] [Full-text]
59. Showered calcific emboli to the brain, the 'salted pretzel' sign, originating from the ipsilateral internal carotid artery causing acute cerebral infarction.
    Stroke, 40(5): e319-21. [Abstract] [Full-text]
60. Low level of low-density lipoprotein cholesterol increases hemorrhagic transformation in large artery atherothrombosis but not in cardioembolism.
    Stroke, 40(5): 1627-32. [Abstract] [Full-text]
61. Hyperglycemia and incidence of ischemic and hemorrhagic stroke-comparison between fasting and 2-hour glucose criteria.
    Stroke, 40(5): 1633-7. [Abstract] [Full-text]
62. Placebo-controlled trial of high-dose atorvastatin in patients with severe cerebral small vessel disease.
    Stroke, 40(5): 1721-8. [Abstract] [Full-text]
63. Cost-effectiveness of patient selection using penumbral-based MRI for intravenous thrombolysis.
    Stroke, 40(5): 1710-20. [Abstract] [Full-text]
64. Fibrinogen independently predicts the development of ischemic stroke in a Taiwanese population: CVDFACTS study.
    Stroke, 40(5): 1578-84. [Abstract] [Full-text]
65. Effects of combined peripheral nerve stimulation and brain polarization on performance of a motor sequence task after chronic stroke.
    Stroke, 40(5): 1764-71. [Abstract] [Full-text]
66. Causes of death by level of dependency at 6 months after ischemic stroke in 3 large cohorts.
    Stroke, 40(5): 1585-9. [Abstract] [Full-text]
67. Prior statin use, intracranial hemorrhage, and outcome after intra-arterial thrombolysis for acute ischemic stroke.
    Stroke, 40(5): 1729-37. [Abstract] [Full-text]
68. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke.
    Stroke, 40(5): 1849-57. [Abstract] [Full-text]
69. Active range of motion predicts upper extremity function 3 months after stroke.
    Stroke, 40(5): 1772-9. [Abstract] [Full-text]
70. Candesartan augments ischemia-induced proangiogenic state and results in sustained improvement after stroke.
    Stroke, 40(5): 1870-6. [Abstract] [Full-text]
71. Sex differences in caspase activation after stroke.
    Stroke, 40(5): 1842-8. [Abstract] [Full-text]
72. Quality of life after intracerebral hemorrhage: results of the Factor Seven for Acute Hemorrhagic Stroke (FAST) trial.
    Stroke, 40(5): 1677-82. [Abstract] [Full-text]
73. Inflammatory and hemostatic biomarkers associated with early recurrent ischemic lesions in acute ischemic stroke.
    Stroke, 40(5): 1653-8. [Abstract] [Full-text]
74. Use of stroke secondary prevention services: are there disparities in care?
    Stroke, 40(5): 1811-9. [Abstract] [Full-text]
75. Reporting standards for angioplasty and stent-assisted angioplasty for intracranial atherosclerosis.
    Stroke, 40(5): e348-65. [Abstract] [Full-text]
76. Future demographic trends decrease the proportion of ischemic stroke patients receiving thrombolytic therapy: a call to set-up therapeutic studies in the very old.
    Stroke, 40(5): 1900-2. [Abstract] [Full-text]
77. MRI mismatch-based intravenous thrombolysis for isolated cerebellar infarction.
    Stroke, 40(5): 1897-9. [Abstract] [Full-text]
78. Green and black tea consumption and risk of stroke: a meta-analysis.
    Stroke, 40(5): 1786-92. [Abstract] [Full-text]
79. Sex differences in the use of intravenous rt-PA thrombolysis treatment for acute ischemic stroke: a meta-analysis.
    Stroke, 40(5): 1743-9. [Abstract] [Full-text]
80. Ice-cold saline for the induction of mild hypothermia in patients with acute ischemic stroke: a pilot study.
    Stroke, 40(5): 1907-9. [Abstract] [Full-text]
81. Would self-expanding stent occlude middle cerebral artery perforators?
    Stroke, 40(5): 1910-2. [Abstract] [Full-text]
82. Estimating blood and brain concentrations and blood-to-brain influx by magnetic resonance imaging with step-down infusion of Gd-DTPA in focal transient cerebral ischemia and confirmation by quantitative autoradiography with Gd-[(14)C]DTPA.
    J Cereb Blood Flow Metab, 29(5): 1048-58. [Abstract] [Full-text]
83. Monocyte subtypes predict clinical course and prognosis in human stroke.
    J Cereb Blood Flow Metab, 29(5): 994-1002. [Abstract] [Full-text]
84. Heme-hemopexin complex attenuates neuronal cell death and stroke damage.
    J Cereb Blood Flow Metab, 29(5): 953-64. [Abstract] [Full-text]
85. Ischemic postconditioning as a novel avenue to protect against brain injury after stroke.
    J Cereb Blood Flow Metab, 29(5): 873-85. [Abstract] [Full-text]
86. Niaspan treatment increases tumor necrosis factor-alpha-converting enzyme and promotes arteriogenesis after stroke.
    J Cereb Blood Flow Metab, 29(5): 911-20. [Abstract] [Full-text]

© 2004-2010 Stroke Research Today. All Rights Reserved.